(7alpha,9alpha)-Sparteine

Basic Information

View in Editor

CAS Number

492-08-0

Molecular Formula

C15H26N2

Molecular Weight

234.39 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Basic Physical Properties

Melting Point

201 ºC

Boiling Point

174°C/8mmHg

Flash Point

148.3±6.8 °C

Refractive Index

n/D 1.527

Vapor Pressure

0.0±0.7 mmHg at 25°C

SMILES

View in Editor

[H][C@]1(C2)[C@](CCCC3)([H])N3C[C@]2([H])[C@@](CCCC4)([H])N4C1

InChI

InChI=1S/C15H26N2/c1-3-7-16-11-13-9-12(14(16)5-1)10-17-8-4-2-6-15(13)17/h12-15H,1-11H2/t12-,13-,14-,15+/m1/s1

InChIKey

SLRCCWJSBJZJBV-TUVASFSCSA-N

LogP

2.3451000000000004

Topological Polar Surface Area

6.48 Å²

Hydrogen Bond Donor/Acceptor

0 / 2

Complexity

263

Safety Information

View Safety Information

Hazard Statement

H302 Harmful if swallowed
Acute toxicity, oral

H315 Causes skin irritation
Skin corrosion/irritation

H319 Causes serious eye irritation
Serious eye damage/eye irritation

Synonyms & References

English

PACHYCARPINE
(+)-Sparteine
Sparteine
(7R,7aR,14R,14aS)-Dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine
d-Sparteine
lupinidine
Sparteine, d-isomer
Genisteine Alkaloid
(-)-Sparteine
Sparteina [DCIT]
Sparteinum [INN-Latin]
Esparteina [INN-Spanish]
Depasan Retard
Sparteine[INN]
Pachycarpine

MDL Number

MFCD00869353

FAQ

What regulatory guidelines apply to (7alpha,9alpha)-Sparteine (CAS: 492-08-0)?

Regulatory guidelines for (7alpha,9alpha)-Sparteine (CAS: 492-08-0) include the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazard communication, REACH regulations for substance registration, evaluation, and authorization in the EU, and FDA/EPA requirements for safety assessments. Proper labeling, storage, and handling are essential to comply with these regulations.

Are there alternatives to (7alpha,9alpha)-Sparteine (CAS: 492-08-0) in synthesis?

Alternatives to (7alpha,9alpha)-Sparteine (CAS: 492-08-0) in synthesis include its structural analogs and isomers, as well as other natural products that serve similar functions. Common alternative reagents include compounds like sparteine derivatives, morpholine derivatives, and other alkaloids, which can be used as substitutes based on specific synthetic requirements.

What is the market or research trend for (7alpha,9alpha)-Sparteine (CAS: 492-08-0)?

The market and research trends for (7alpha,9alpha)-Sparteine (CAS: 492-08-0) are currently focusing on its potential biological activities, such as anti-inflammatory and antispasmodic properties. Recent studies have explored its use in traditional medicine and pharmaceutical applications, driving research interest and market demand.

How should waste containing (7alpha,9alpha)-Sparteine (CAS: 492-08-0) be handled?

Waste containing (7alpha,9alpha)-Sparteine (CAS: 492-08-0) should be collected and disposed of in accordance with local and international environmental regulations. Proper incineration or professional waste disposal services should be used, and environmental protection precautions, such as minimizing exposure and preventing contamination, must be taken during handling and disposal processes.